Showing results (371-380 of 606) with videos related to

Sort By:
Pageof 61
Pharmacoeconomics - Open|February 15, 2018
Model-Based Economic Evaluation of Treatments for Depression: A Systematic Literature ReviewSpyros Kolovos, Judith E Bosmans, Heleen Riper, et al.
Pharmacoeconomics - Open|February 15, 2018
Evaluating the Treatment Costs for Uncomplicated Malaria at a Public Healthcare Facility in Nigeria and the ImplicationsCharles C Ezenduka, Daniel Resende Falleiros, Brian B Godman
Pharmacoeconomics - Open|February 15, 2018
Cost of Illness of Japanese Patients with Chronic Lymphocytic Leukemia (CLL), and Budget Impact of the Market Introduction of IbrutinibJörg Mahlich, Shinichiro Okamoto, Akiko Tsubota
Pharmacoeconomics - Open|February 15, 2018
Economic Impact of Mirabegron Versus Antimuscarinics for the Treatment of Overactive Bladder in the UKJameel Nazir, Malin Berling, Charles McCrea, et al.
Pharmacoeconomics - Open|January 9, 2019
Economic Evaluation of Nivolumab Plus Ipilimumab Combination as First-Line Treatment for Patients with Advanced Melanoma in CanadaPeter L Quon, Ying Xiao, Sonja Sorensen, et al.
Pharmacoeconomics - Open|January 19, 2019
Estimated Versus Observed Expenditure Associated with Medicines Recommended by the All Wales Medicines Strategy GroupStuart Keeping, Paul N Deslandes, Kathryn E Haines, et al.
Pharmacoeconomics - Open|August 23, 2025
Identifying Potential Gaps in Care for Patients with Higher-Risk Myelodysplastic Syndromes in a Large US Health SystemKristin J Moore, Nicole M Engel-Nitz, Peter McMahon, et al.
Pageof 61